Document is current
Any future updates will be listed below
-
Authors
Zambusi, Alessandro
Novoselc, Klara Tereza
Hutten, Saskia
Kalpazidou, Sofia
Koupourtidou, Christina https://orcid.org/0000-0002-8352-1498
Schieweck, Rico
Aschenbroich, Sven
Silva, Lara
Yazgili, Ayse Seda https://orcid.org/0000-0001-8485-9653
van Bebber, Frauke
Schmid, Bettina https://orcid.org/0000-0001-8043-7269
Möller, Gabriel https://orcid.org/0000-0002-8731-4330
Tritscher, Clara
Stigloher, Christian https://orcid.org/0000-0001-6941-2669
Delbridge, Claire
Sirko, Swetlana https://orcid.org/0000-0001-5950-616X
Günes, Zeynep Irem
Liebscher, Sabine https://orcid.org/0000-0001-5633-8981
Schlegel, Jürgen
Aliee, Hananeh
Theis, Fabian https://orcid.org/0000-0002-2419-1943
Meiners, Silke
Kiebler, Michael
Dormann, Dorothee https://orcid.org/0000-0002-9260-2775
Ninkovic, Jovica https://orcid.org/0000-0002-4381-0041
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SPP1757)
Fritz Thyssen Stiftung
- License Information
-
More Information
Article History
Received: 27 April 2021
Accepted: 11 October 2022
First Online: 24 November 2022
Competing interests
: The authors declare the following competing interests: F.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Omniscope Ltd, and has ownership interest in Dermagnostix GmbH and Cellarity. All other authors declare no competing interests.
